Long-term retention rate of pramipexole in the treatment of Parkinson’s disease

被引:0
|
作者
Tapani Keränen
Mervi Tuhkasaari
Hanna Kuusisto
机构
[1] Tampere University Hospital,Division of Neurology and Rehabilitation
[2] University of Kuopio,Department of Pharmacology and Toxicology
关键词
Outcome; Parkinson’s disease; Pramipexole; Retention rate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:955 / 956
页数:1
相关论文
共 50 条
  • [31] Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
    Piedad, John C. P.
    Cavanna, Andrea E.
    PARKINSONS DISEASE, 2012, 2012
  • [32] The benefits of pramipexole selection in the treatment of Parkinson's disease
    Silindir, Mine
    Ozer, A. Yekta
    NEUROLOGICAL SCIENCES, 2014, 35 (10) : 1505 - 1511
  • [33] The benefits of pramipexole selection in the treatment of Parkinson’s disease
    Mine Silindir
    A. Yekta Ozer
    Neurological Sciences, 2014, 35 : 1505 - 1511
  • [34] LSVT BIG (R) and long-term retention of functional gains in individuals with Parkinson's disease
    Fleming Walsh, Sharon
    Balster, Courtney
    Chandler, Aaron
    Brown, Jennifer
    Boehler, Mark
    O'Rear, Stephen
    PHYSIOTHERAPY THEORY AND PRACTICE, 2022, 38 (05) : 629 - 636
  • [35] Long-term efficacy of globus pallidus stimulation for the treatment of Parkinson's disease
    Lyons, KE
    Wilkinson, SB
    Tröster, AI
    Pahwa, R
    STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2002, 79 (3-4) : 214 - 220
  • [36] Ropinirole is effective in long-term treatment of patients with early Parkinson's disease
    Larsen, JP
    Brunt, E
    Korczyn, AD
    Nagy, Z
    Poewe, W
    Ruggieri, S
    NEUROLOGY, 1998, 50 (04) : A277 - A278
  • [37] Early introduction of dopamine agonists in the long-term treatment of Parkinson's disease
    Ogawa, N
    NEUROLOGY, 1998, 51 (02) : S13 - S20
  • [38] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
    Waters, CH
    Kurth, M
    Bailey, P
    Shulman, LM
    LeWitt, P
    Dorflinger, E
    Deptula, D
    Pedder, S
    NEUROLOGY, 1997, 49 (03) : 665 - 671
  • [39] Long-term bilateral subthalamic nucleus stimulation for the treatment of Parkinson's disease
    Van Blercom, N
    Charles, D
    Limousin, P
    Krack, P
    Benazzouz, A
    Ardouin, C
    Koudsie, A
    Xie, J
    Benabid, AL
    Pollak, P
    NEUROLOGY, 1999, 52 (06) : A271 - A271
  • [40] Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs
    Mizuno, Yoshikuni
    Shimoda, Satoe
    Origasa, Hideki
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (01) : 35 - 43